SALE EXTENDED
MarketBeat All Access
Start your 30-day free trial,
then continue your subscription for 50% off.
TODAY ONLY!
Claim Your Discount
×
S&P 500   3,744.52
DOW   29,926.94
QQQ   279.76
5 Unspoken Rules You Need to Know When Starting a Media Agency
Live Updates: Russia-Ukraine War
Box Inc. Stock on Track to Become a Q4 Winner
3 Stocks With Market-Beating Price Performance
Don’t Chase American Virtual Cloud Technologies Higher
Is Ford's Revenue Enough to Juice its Stock Price?
Will WWE Shares Wrestle Their Way Higher or Will They Tap Out?
S&P 500   3,744.52
DOW   29,926.94
QQQ   279.76
5 Unspoken Rules You Need to Know When Starting a Media Agency
Live Updates: Russia-Ukraine War
Box Inc. Stock on Track to Become a Q4 Winner
3 Stocks With Market-Beating Price Performance
Don’t Chase American Virtual Cloud Technologies Higher
Is Ford's Revenue Enough to Juice its Stock Price?
Will WWE Shares Wrestle Their Way Higher or Will They Tap Out?
S&P 500   3,744.52
DOW   29,926.94
QQQ   279.76
5 Unspoken Rules You Need to Know When Starting a Media Agency
Live Updates: Russia-Ukraine War
Box Inc. Stock on Track to Become a Q4 Winner
3 Stocks With Market-Beating Price Performance
Don’t Chase American Virtual Cloud Technologies Higher
Is Ford's Revenue Enough to Juice its Stock Price?
Will WWE Shares Wrestle Their Way Higher or Will They Tap Out?
S&P 500   3,744.52
DOW   29,926.94
QQQ   279.76
5 Unspoken Rules You Need to Know When Starting a Media Agency
Live Updates: Russia-Ukraine War
Box Inc. Stock on Track to Become a Q4 Winner
3 Stocks With Market-Beating Price Performance
Don’t Chase American Virtual Cloud Technologies Higher
Is Ford's Revenue Enough to Juice its Stock Price?
Will WWE Shares Wrestle Their Way Higher or Will They Tap Out?
NASDAQ:CSII

Cardiovascular Systems - CSII Stock Forecast, Price & News

$13.74
-0.24 (-1.72%)
(As of 10/6/2022 12:00 AM ET)
Add
Compare
Today's Range
$13.64
$14.08
50-Day Range
$12.93
$17.17
52-Week Range
$12.51
$36.97
Volume
149,243 shs
Average Volume
275,229 shs
Market Capitalization
$575.84 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$30.00

Cardiovascular Systems MarketRank™ Forecast

Analyst Rating
Hold
2.20 Rating Score
Upside/​Downside
118.3% Upside
$30.00 Price Target
Short Interest
Bearish
3.59% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.01
Upright™ Environmental Score
News Sentiment
0.69mentions of Cardiovascular Systems in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.67) to ($0.50) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.10 out of 5 stars

Medical Sector

591st out of 1,075 stocks

Surgical & Medical Instruments Industry

63rd out of 104 stocks

CSII stock logo

About Cardiovascular Systems (NASDAQ:CSII) Stock

Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products. It also provides Diamondback 360 Coronary orbital atherectomy systems (OAS), a coronary artery disease (CAD) product designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to severely calcified coronary artery lesions. In addition, it offers guidewires, catheters, balloons, embolic protection system, and other OAS support products. Cardiovascular Systems, Inc. has a partnership with Chansu Vascular Technologies, LLC to develop novel peripheral and coronary everolimus drug-coated balloons. The company was formerly known as Shturman Cardiology Systems, Inc. and changed its name to Cardiovascular Systems, Inc. in January 2003. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in Saint Paul, Minnesota.

Receive CSII Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardiovascular Systems and its competitors with MarketBeat's FREE daily newsletter.

CSII Stock News Headlines

Cardiovascular Systems, Inc. (CSII)
Cardiovascular Systems Tops Q3 EPS by 3c
Cardiovascular Systems Q3 2022 Earnings Preview
See More Headlines
Receive CSII Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardiovascular Systems and its competitors with MarketBeat's FREE daily newsletter.

CSII Company Calendar

Last Earnings
8/02/2022
Today
10/07/2022
Next Earnings (Estimated)
11/08/2022
Fiscal Year End
6/30/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NASDAQ:CSII
CUSIP
14161910
Employees
780
Year Founded
1989

Price Target and Rating

Average Stock Price Forecast
$30.00
High Stock Price Forecast
$40.00
Low Stock Price Forecast
$20.00
Forecasted Upside/Downside
+118.3%
Consensus Rating
Hold
Rating Score (0-4)
2.20
Research Coverage
5 Analysts

Profitability

Net Income
$-36,930,000.00
Pretax Margin
-15.50%

Debt

Sales & Book Value

Annual Sales
$236.22 million
Book Value
$6.12 per share

Miscellaneous

Free Float
40,314,000
Market Cap
$575.84 million
Optionable
Optionable
Beta
0.88

Social Links


Key Executives

  • Mr. Scott Raymond Ward B.Sc. (Age 62)
    M.S., MS, Chairman, Pres & CEO
    Comp: $1.46M
  • Mr. Jeffrey S. PointsMr. Jeffrey S. Points (Age 44)
    Chief Financial Officer
    Comp: $682.69k
  • Mr. Alexander Rosenstein (Age 50)
    Gen. Counsel & Corp. Sec.
    Comp: $614.96k
  • Mr. John E. Nielsen
    VP of Investor Relations & Corp. Communications
  • Ms. Sandra M. Sedo (Age 58)
    Chief Compliance Officer
  • Mr. Stephen J. Rempe (Age 49)
    Chief HR Officer
  • Dr. Jeffrey W. Chambers M.D.
    Chief Medical Officer













CSII Stock - Frequently Asked Questions

Should I buy or sell Cardiovascular Systems stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardiovascular Systems in the last year. There are currently 1 sell rating, 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CSII shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CSII, but not buy additional shares or sell existing shares.
View CSII analyst ratings
or view top-rated stocks.

What is Cardiovascular Systems' stock price forecast for 2022?

5 Wall Street analysts have issued 12 month target prices for Cardiovascular Systems' shares. Their CSII share price forecasts range from $20.00 to $40.00. On average, they predict the company's share price to reach $30.00 in the next year. This suggests a possible upside of 118.3% from the stock's current price.
View analysts price targets for CSII
or view top-rated stocks among Wall Street analysts.

How have CSII shares performed in 2022?

Cardiovascular Systems' stock was trading at $18.78 on January 1st, 2022. Since then, CSII shares have decreased by 26.8% and is now trading at $13.74.
View the best growth stocks for 2022 here
.

When is Cardiovascular Systems' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 8th 2022.
View our CSII earnings forecast
.

How were Cardiovascular Systems' earnings last quarter?

Cardiovascular Systems, Inc. (NASDAQ:CSII) posted its earnings results on Tuesday, August, 2nd. The medical device company reported ($0.25) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.22) by $0.03. The medical device company earned $62.50 million during the quarter, compared to analysts' expectations of $62.88 million. Cardiovascular Systems had a negative net margin of 15.64% and a negative trailing twelve-month return on equity of 14.40%.

What guidance has Cardiovascular Systems issued on next quarter's earnings?

Cardiovascular Systems updated its FY 2023 earnings guidance on Wednesday, August, 10th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $255.00 million-$265.00 million, compared to the consensus revenue estimate of $236.73 million.

What is Scott Ward's approval rating as Cardiovascular Systems' CEO?

35 employees have rated Cardiovascular Systems Chief Executive Officer Scott Ward on Glassdoor.com. Scott Ward has an approval rating of 81% among the company's employees. 83.0% of employees surveyed would recommend working at Cardiovascular Systems to a friend.

What other stocks do shareholders of Cardiovascular Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardiovascular Systems investors own include Gilead Sciences (GILD), AbbVie (ABBV), Advanced Micro Devices (AMD), Medtronic (MDT), Pfizer (PFE), ACADIA Pharmaceuticals (ACAD), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK) and Procter & Gamble (PG).

What is Cardiovascular Systems' stock symbol?

Cardiovascular Systems trades on the NASDAQ under the ticker symbol "CSII."

How do I buy shares of Cardiovascular Systems?

Shares of CSII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cardiovascular Systems' stock price today?

One share of CSII stock can currently be purchased for approximately $13.74.

How much money does Cardiovascular Systems make?

Cardiovascular Systems (NASDAQ:CSII) has a market capitalization of $575.79 million and generates $236.22 million in revenue each year. The medical device company earns $-36,930,000.00 in net income (profit) each year or ($0.95) on an earnings per share basis.

How many employees does Cardiovascular Systems have?

The company employs 780 workers across the globe.

How can I contact Cardiovascular Systems?

Cardiovascular Systems' mailing address is 1225 OLD HWY 8 NW, ST. PAUL MN, 55112. The official website for the company is www.csi360.com. The medical device company can be reached via phone at (651) 259-1600, via email at j.nielsen@csi360.com, or via fax at 612-677-3355.

This page (NASDAQ:CSII) was last updated on 10/7/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.